NEW YORK (GenomeWeb News) – Sequenom announced yesterday that Invitrogen will be the exclusive distributor of its MassArray systems and consumable products in South and Central America.

“Among our top priorities is expanding our geographic reach and this agreement provides us with an entrée into Central and South America, regions where we see a substantial opportunity but have had little exposure,” Michael Monko, SVP of sales and marketing for Sequenom, said in a statement.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Congress approved a bill Friday that would increase the US National Institutes of Health's funding by $2 billion for fiscal year 2019.

UK's Labour Party calls for a ban on non-invasive prenatal testing for determining sex, BBC News reports.

Sarah Lawrence College's Laura Hercher warns in a New York Times op-ed that more people are going to need help figuring out what their consumer genetic testing results mean.

In PLOS this week: intra-tumor heterogeneity patterns, genomic analysis of Thoroughbred horse origins, and more.